Getinge AB (publ) (ADR)
General ticker "GNGBY" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $5.9B (TTM average)
Getinge AB (publ) (ADR) follows the US Stock Market performance with the rate: 28.1%.
Estimated limits based on current volatility of 1.7%: low 20.23$, high 20.94$
Factors to consider:
- Company pays dividends (annually): last record date 2026-04-23, amount 0.51$ (Y2.54%)
- Price in estimated range
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [18.40$, 29.00$]
- 2026-12-31 to 2027-12-31 estimated range: [19.47$, 30.55$]
Financial Metrics affecting the GNGBY estimates:
- Positive: with PPE of 20.2 at the end of fiscal year the price was neutral
- Positive: 7.54 < Operating profit margin, % of 10.84
- Positive: Industry inventory ratio change (median), % of -0.30 <= -0.16
- Positive: 1.81 < Return on assets ratio (scaled to [-100,100]) of 3.84
- Positive: -0.02 < Operating cash flow per share per price, % of 6.37
- Positive: 42.59 < Shareholder equity ratio, % of 52.08 <= 64.29
- Negative: Investing cash flow per share per price, % of -4.78 <= -4.41
- Positive: Inventory ratio change, % of -1.25 <= -0.75
Short-term GNGBY quotes
Long-term GNGBY plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | SEK31,827.00MM | SEK34,759.00MM | SEK34,969.00MM |
| Operating Expenses | SEK28,091.00MM | SEK31,905.00MM | SEK31,180.00MM |
| Operating Income | SEK3,736.00MM | SEK2,854.00MM | SEK3,789.00MM |
| Non-Operating Income | SEK-393.00MM | SEK-572.00MM | SEK-644.00MM |
| Interest Expense | SEK469.00MM | SEK606.00MM | SEK484.09MM |
| R&D Expense | SEK1,696.00MM | SEK1,431.00MM | SEK1,452.00MM |
| Income(Loss) | SEK3,343.00MM | SEK2,282.00MM | SEK3,145.00MM |
| Taxes | SEK915.00MM | SEK628.00MM | SEK869.00MM |
| Net Income(Loss)* | SEK2,412.00MM | SEK1,638.00MM | SEK2,258.00MM |
| Stockholders Equity | SEK30,166.00MM | SEK33,005.00MM | SEK29,429.00MM |
| Inventory | SEK6,416.00MM | SEK6,590.00MM | SEK6,018.00MM |
| Assets | SEK53,586.00MM | SEK63,918.00MM | SEK56,505.00MM |
| Operating Cash Flow | SEK2,957.00MM | SEK4,577.00MM | SEK3,712.96MM |
| Capital expenditure | SEK1,353.00MM | SEK1,309.00MM | SEK1,235.15MM |
| Investing Cash Flow | SEK-6,543.00MM | SEK-4,549.00MM | SEK-2,782.37MM |
| Financing Cash Flow | SEK511.00MM | SEK504.00MM | SEK-719.09MM |
| Earnings Per Share** | SEK8.86 | SEK6.01 | SEK8.29 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.